NASDAQ:BIOX Bioceres Crop Solutions Q2 2026 Earnings Results & Report $0.29 -0.01 (-2.03%) Closing price 03:54 PM EasternExtended Trading$0.30 +0.01 (+1.70%) As of 04:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Bioceres Crop Solutions missed analyst expectations on both earnings and revenue in its Q2 2026 results, released March 13, 2026. The company reported EPS of -$0.08 versus the $0.07 consensus estimate, while revenue of $73.81 million fell short of the $104.55 million estimate by $30.74 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateMarch 13, 2026TimeBefore Market OpensConference Call DateMarch 16, 2026Conference Call8:00 AM ET Bioceres Crop Solutions EPS ResultsActual EPS-$0.08Consensus EPS $0.07Beat/MissMissed by -$0.15One Year Ago EPSN/AEPS Beat Rate2 of last 8 quartersBioceres Crop Solutions Revenue ResultsActual Revenue$73.81 millionExpected Revenue$104.55 millionBeat/MissMissed by -$30.74 millionYoY Revenue GrowthN/AUpcoming EarningsBioceres Crop Solutions' Q1 2027 earnings is estimated for Thursday, November 12, 2026, based on past reporting schedules, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (6-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(6-K) Bioceres Crop Solutions Q2 2026 Earnings FAQ Did Bioceres Crop Solutions beat earnings estimates for Q2 2026? Bioceres Crop Solutions (NASDAQ:BIOX) reported earnings of -$0.08 per share for Q2 2026, missing the consensus estimate of $0.07. The report was announced on Friday, March 13, 2026. What was Bioceres Crop Solutions' revenue for Q2 2026? Bioceres Crop Solutions reported revenue of $73.81 million for Q2 2026, against a consensus estimate of $104.55 million. When is Bioceres Crop Solutions' next earnings date? Bioceres Crop Solutions' next earnings date is estimated for Thursday, November 12, 2026. MarketBeat tracks confirmed and estimated earnings dates for Bioceres Crop Solutions on the company's earnings history page. Bioceres Crop Solutions Earnings HeadlinesComparing Bioceres Crop Solutions (NASDAQ:BIOX) and Chemours (NYSE:CC)October 8, 2026 | americanbankingnews.comBioceres (BIOX) Q4 2026 Earnings Call TranscriptSeptember 15, 2026 | finance.yahoo.comALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.October 15 at 1:00 AM | Weiss Ratings (Ad)Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating ResultsSeptember 14, 2026 | businesswire.comBioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2026 Financial Results Conference Call on Tuesday, September 15, 2026 at 8:30 a.m. Eastern TimeSeptember 9, 2026 | businesswire.comBioceres Crop Solutions Corp (BIOX) Q3 2026 Earnings Call Highlights: Navigating Challenges ...May 14, 2026 | finance.yahoo.comSee More Bioceres Crop Solutions Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Bioceres Crop Solutions? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bioceres Crop Solutions and other key companies, straight to your email. Email Address About Bioceres Crop SolutionsBioceres Crop Solutions (NASDAQ:BIOX) (NASDAQ:BIOX) is an Argentina-based agricultural biotechnology company focused on developing technologies that improve crop productivity, resilience and sustainability. Its offerings include genetically enhanced seeds, biological crop inputs, seed treatments, biostimulants, fertilizers and crop protection products designed for use across major field crops. The company is best known for its HB4 technology, a drought-tolerance trait developed for wheat and soybeans. Bioceres has also developed biological products, including microbial inoculants and other solutions intended to improve nutrient use and plant performance. Its product portfolio is marketed primarily through agricultural distribution channels and serves farmers in Argentina and other markets across the Americas, as well as selected international regions. Bioceres traces its roots to Argentina’s agricultural biotechnology sector and expanded its portfolio through the integration of businesses such as Rizobacter, an established producer of biological and crop-input products. The company is led by Chief Executive Officer Federico Trucco, who has been involved in the development and commercialization of its agricultural biotechnology platform.View Bioceres Crop Solutions ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpFastenal Flashes Bullish Signal as Uptrend Holds Despite Margin PressureASML Can’t Keep Up With AI Demand—Why That's a Good ThingCiti Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenBig Banks Report Strong Earnings—So Why Are Shares Falling? Upcoming Earnings Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
